Premium
Efficacy and safety of high‐dose peanut oral immunotherapy with factors predicting outcome
Author(s) -
Anagnostou K.,
Clark A.,
King Y.,
Islam S.,
Deighton J.,
Ewan P.
Publication year - 2011
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/j.1365-2222.2011.03699.x
Subject(s) - medicine , oral immunotherapy , peanut allergy , immunotherapy , maintenance dose , allergy , oral food challenge , immunoglobulin e , gastroenterology , immunology , food allergy , antibody , cancer
Peanut allergy is severe and rarely resolves.